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Background:  Atherosclerosis  and  arterial  stiffening  may  coexist  and  the correlation  of these  parameters
in  patients  with  premature  coronary  artery  disease  (CAD)  has  not  been  well  elucidated.  Tissue  Doppler
imaging  of the  ascending  aorta  may  be used  in  the  assessment  of  elastic  properties  of  the  great  arteries.
Objective:  To  investigate  the  correlation  between  aortic  stiffness  and  premature  CAD using parameters
derived  from  two-dimensional  and  tissue  Doppler  imaging  (TDI)  echocardiography  of  the  ascending
aorta.
Methods:  Fifty consecutive  subjects  younger  than 40 years  old  who  were  hospitalized  with  diagnosis
of  acute  coronary  syndrome  and  had  undergone  coronary  angiography  were  recruited.  The  control
group  included  70 age–sex  matched  individuals  without  a  diagnosis  of  CAD.  Aortic  stiffness  index
(SI),  aortic  distensibility  (D), and  pressure-strain  elastic  modulus  (Ep)  were  calculated  from  the  aortic
diameters  measured  by  two-dimensional  M-mode  echocardiography  and  blood  pressure  obtained  by
sphygmomanometry.  Aortic  systolic  velocity  (SAo), and  early  (EAo) and  late  (AAo)  diastolic  velocities  were
determined  by pulse-wave  TDI from  the  anterior  wall of ascending  aorta  3 cm  above  the  aortic  cusps  in
parasternal  long-axis  view.
Results:  Stiffness  index  was  higher  [median  5.40,  interquartile  range  (IQR)  5.98  vs. median  4.14  IQR
2.43;  p =  0.03]  and  distensibility  was  lower  (median  2.86  ×  10−6 cm2/dyn,  IQR  2.51 × 10−6 cm2/dyn  vs.
median 3.46  × 10−6 cm2/dyn,  IQR  2.38  ×  10−6 cm2/dyn;  p = 0.04)  in patients  with  CAD  compared  to  the
control  group.  EAo was signiﬁcantly  lower  in  the CAD  group  (7.2  ±  1.8 cm/s  vs. 9.2 ±  2.4 cm/s,  p  < 0.01).
The  difference  in EAo remained  signiﬁcant  when  CAD  patients  with  a  left ventricular  ejection  fraction
>55%  was  compared  to the  control  group.  SAo and  AAo velocities  of  ascending  aorta  were  similar  in  con-
trol  and  CAD  groups.  There was a signiﬁcant  correlation  between  EAo velocity  and  aortic  stiffness  index
(r  = −0.28,  p = 0.01),  distensibility  (r  =  0.19,  p  = 0.04)  and  elastic  modulus  (r =  −0.24,  p = 0.01).  In multivari-
ate regression  analysis,  decreased  levels  of high-density  lipoprotein  cholesterol  [odds  ratio  (OR):  1.12
95% CI  1.06–1.19;  p = 0.01]  and  EAo (OR:  1.41  95%  CI 1.12–1.79;  p  = 0.01)  measurements  remained  as  the
variables  independently  correlated  with  premature  CAD  in  the  study  group.
Conclusion:  Arterial  stiffness  is  increased  in patients  with  premature  CAD.  EAo of  the anterior  wall  of
ascending  aorta  measured  with  pulse-wave  TDI  echocardiography  is correlated  with  arterial  stiffening
ts  w
3  Japand  is  decreased  in patien
© 201
ntroductionThe normal aging process is associated with an increase in
ascular stiffness which is accelerated by atherosclerosis, hyper-
ension, and diabetes mellitus [1–4]. Several studies have revealed
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that increased aortic stiffness (AS) is a risk factor for cardiovascular
(CV) diseases and also is a predictor of CV morbidity and mortality
[5–9]. In addition, arterial stiffening is increased in individuals with
a family history of premature coronary artery disease (CAD) which
may  indicate a genetic predisposition to CAD [10].
Two-dimensional and tissue Doppler imaging (TDI)-derived
parameters of ascending aorta have been found to be abnormal,
indicating increased AS in subjects with CAD, hypertension, and
diabetes mellitus [11,12]. However, the direct correlation of AS
with CAD is hard to examine as most of these patients are old
and have comorbidities such as hypertension and diabetes mellitus.
vier Ltd. All rights reserved.
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nvestigation of these parameters in patients with premature CAD
ay  yield valuable information as most of these patients do not
ave confounding factors that increase AS.
Thus, the aim of this study was to investigate the correlation of
he aortic wall velocities assessed by TDI echocardiography with
AD in subjects younger than 40 years of age.
ethods
The study population consisted of 50 patients (male 41, female
) who were younger than 40 years of age and were hospitalized
ith the diagnosis of acute coronary syndrome in Dr. Siyami Ersek
ardiovascular and Thoracic Surgery Center, Istanbul between
anuary 2010 and June 2012. Clinical data including past medi-
al history, smoking status, family history, and medications were
btained from patient interview and chart review. Fasting blood
amples were collected on the ﬁrst day of hospitalization.
Hypercholesterolemia, hypertension, and diabetes mellitus
ere deﬁned either as self reported, documented diagnosis
btained from chart review, or current treatment with medica-
ion. Hypertension was deﬁned as a systolic pressure > 140 mmHg
nd/or a diastolic pressure > 90 mmHg  or if the individual was tak-
ng antihypertensive medications. Diabetes mellitus was  deﬁned
s a fasting glucose level >126 mg/dl and/or if the patient was  tak-
ng anti-diabetic medication. Hypercholesterolemia was  deﬁned as
otal cholesterol of at least 200 mg/dl or use of cholesterol-lowering
gents. Positive family history for CAD was deﬁned as documented
vidence of CAD in a ﬁrst-degree relative before 60 years of age.
ndividuals who reported smoking of at least one cigarette per day
uring the year before examination were classiﬁed as smokers. Car-
iac medications taken at study entry were recorded. The weight
nd stature were measured and body mass index (BMI) values were
alculated as weight (kg)/height (m2).
All of the subjects underwent diagnostic coronary angiography
uring index hospitalization. CAD was diagnosed as the presence
f a lumen diameter reduction >50% in ≥1 major coronary artery.
ercutaneous coronary intervention was performed as indicated.
Exclusion criteria were: age >40 years; left ventricular ejection
raction (LVEF) <50%; severe valvular disease; history of coronary
rtery bypass grafting operation; heart rhythm other than sinus.
The control group was composed of 70 (58 male, 12 female)
ubjects who were admitted to the outpatient clinic. All of the
ontrol subjects had normal ﬁndings in the physical examination,
2-lead electrocardiography, and transthoracic echocardiography.
he echocardiographic examination was performed after 6 hours
f abstinence from smoking. All patients gave informed consent to
articipate in the study and the local ethical committee approved
he study.
chocardiography
All patients underwent echocardiography in the left lateral
ecubitus position on the day of discharge. Studies were performed
sing a commercially available system (VIVID 7; General Electric
ingmed Ultrasound, Milwaukee, WI,  USA). Images were obtained
sing a 3.5-MHz transducer, at a depth of 16 cm in the paraster-
al (long- and short-axis) and apical (2- and 4-chamber) views.
tandard 2-D and color Doppler data, triggered to the QRS com-
lex, were saved in cineloop format. A minimum of 3 consecutive
eats were recorded from each view, and the images were digitally
tored for ofﬂine analysis. All of the images were obtained at end-
xpiration as recommended. All echocardiographic ﬁndings were
nalyzed by one of the authors, who were blinded to the subjects’
ast histories.iology 63 (2014) 223–229
Aortic diameters were measured at a level 3 cm above the aor-
tic cusps in long axis from the parasternal view (Fig. 1). M-mode
diameter measurements were made in systole (point of maximal
anterior motion of aorta) and at end-diastole (q wave on electrocar-
diogram). The means of ﬁve diameter measurements in sequential
cardiac cycles were used for data analysis. Systemic arterial blood
pressure (BP) was  measured at the right brachial artery by manual
sphygmomanometer with the patient supine using an adequately
sized cuff. BP was  measured three times on each occasion at 2 min
intervals and averaged. Pulse pressure (PP) was obtained by sub-
tracting the diastolic BP from the systolic BP. Antihypertensive
drugs were not discontinued on the day of the examination. Control
subjects refrained from smoking for at least 12 h before the echocar-
diographic examination. Patients with CAD had not smoked during
the hospitalization period which accounts for 3–4 days before the
examination.
The elastic properties of the aorta were indexed by calculation of
aortic distensibility (D), stiffness index (SI) and pressure strain elas-
tic modulus (Ep) and were as follows: D = 2 (As − Ad)/[Ad (Ps − Pd)],
SI = ln(Ps/Pd)/[(As − Ad)/Ad] and Ep = (Ps − Pd)/[(As − Ad)/Ad], respec-
tively, where As is the aortic diameter at end-systole, Ad is the aortic
diameter at end-diastole, Ps is the systolic BP, Pd is the diastolic BP,
and ln is the natural logarithm [13–15].
Measurements of cardiac chambers were made by transthoracic
echocardiography according to established criteria [16–18]. Peak
early (E) and late (A) diastolic velocities, deceleration time, left
ventricular (LV) isovolumic relaxation time (IRT) were obtained
from apical four-chamber view using standard Doppler practices
[19–21].
Tissue Doppler imaging
Aortic upper-wall velocities were measured by TDI at the same
point as in the M-mode measurements (Fig. 1). Gain and ﬁlter
settings were adjusted to optimize the image. High temporal res-
olution (>100 frames/s) and a sweep speed set to 100 mm/s  were
used. The TDI of expansion peak velocity during systole (SAo) and
early (EAo) and late (AAo) contraction peak velocities during dias-
tole were obtained with a 1-mm sample volume size. The resulting
velocities were recorded for 5–10 cardiac cycles and stored for later
playback and analysis. The averages of velocities measured from the
septal and lateral mitral annulus on the transthoracic four-chamber
views were reported as Sa, Ea, Aa [22,23].
Statistics
The data were analyzed using SPSS version 13.0 software (SPSS,
Chicago, IL, USA). All of the data are expressed as arithmetic
mean ± SD or median (interquartile range; IQR) for skewed vari-
ables. The differences between the groups were explored using the
Student’s t-test and the Mann–Whitney U-test. Differences in pro-
portions between groups were assessed for statistical signiﬁcance
using the chi-square test. As the LVEF was signiﬁcantly different
between the two groups, we also performed an ANCOVA analysis,
putting the aortic stiffness parameters as the dependent variables,
patient group as the ﬁxed factor and LVEF, Ea, and smoking sta-
tus as the covariate. The relationships between parameters were
evaluated by Spearman’s rank correlation analysis or linear regres-
sion analysis. Multiple stepwise logistic regression analysis was
performed to examine the correlates of CAD. Differences were con-
sidered statistically signiﬁcant when the p-value was <0.05.
Reproducibility for the measurements of the aortic velocities
by TDI method was  examined in 25 randomly selected cases.
Intra-observer and inter-observer variability were estimated by
measuring the Lin’s concordance correlation coefﬁcient. Concord-
ance correlation coefﬁcients were 0.92 (95% CI 0.843–0.966) for SAo,
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tig. 1. M-mode and pulse-wave tissue Doppler imaging echocardiography record
ortic  systolic/diastolic diameters and systolic (SAo), early diastolic (EAo), and late d
evel  3 cm above the aortic cusps. Diastolic recoil of the aorta occurs mainly during 
.94 (95% CI, 0.891–0.976) for EAo, and 0.85 (95% CI 0.707–0.932) for
Ao within the same observer. Concordance correlation coefﬁcients
ere 0.93 (95% CI 0.856–0.969) for SAo, 0.95 (95% CI, 0.904–0.976)
or EAo, and 0.93 (95% CI 0.854–0.967) for AAo between the 2
bservers.
esults
The characteristics of the study population and control group
re shown in Table 1. There were no signiﬁcant differences between
he groups regarding age, gender, BMI, baseline BP, and coronary
isk factors including hypertension, diabetes mellitus, and smoking
tatus. Subjects with hyperlipidemia and positive family history for
AD were more frequent in the CAD group. Fasting glucose level
as higher and high-density lipoprotein (HDL) cholesterol level
as lower in the CAD group. Most of the patients had ST segment
levation, myocardial infarction, and the coronary angiograms
evealed critical stenosis of left anterior descending artery as the
ost frequent culprit lesion.
Echocardiographic ﬁndings in study subjects are depicted in
able 2. LV systolic and diastolic diameters and LV mass and mass
ndex were signiﬁcantly higher, and LVEF was signiﬁcantly lower
n the CAD group (p < 0.01 for all comparisons). Mitral valve pulse
ave parameters were similar in both groups. However, in the CAD
roup, early diastolic mitral annular TDI velocity, Ea was  signiﬁ-
antly lower.
Stiffness index was higher (median 5.40, IQR 5.98 vs.
edian 4.14 IQR 2.43; p = 0.03) and distensibility was  lower
median 2.86 × 10−6 cm2/dyn, IQR 2.51 × 10−6 cm2/dyn vs. median
.46 × 10−6 cm2/dyn, IQR 2.38 × 10−6 cm2/dyn; p = 0.04) in patients
ith CAD compared to the control group (Table 2). Measurement
f ascending aorta pulse wave TDI parameters was performed suc-
essfully in all study participants. Early diastolic velocity of aorta
EAo) was signiﬁcantly lower in the CAD group (7.2 ±1.8 cm/s vs.
.2 ±2.4 cm/s, p < 0.01). Systolic (SAo) and late diastolic (AAo) veloc-
ties of ascending aorta were similar in the control and CAD groups.
n ANCOVA analysis using model adjusted for LVEF, Ea veloci-
ies, and smoking status, EAo velocities were signiﬁcantly lowerf the ascending aorta in parasternal long-axis view showing the measurement of
c (AAo) aortic wall velocities. The measurements were made at the same point at a
rly diastole concurrent with the EAo velocity.
in the premature CAD group compared to the controls (adjusted
mean: 7.66 cm/s, 95% CI: 6.97–8.36 cm/s vs. mean: 8.93 cm/s, 95%
CI: 8.37–9.49 cm/s, respectively; p = 0.02). Using the same model,
SAo and AAo velocities were not signiﬁcantly different between the
two groups (p = 0.16 and p = 0.19, respectively).
In subgroup analysis, when CAD patients with a LVEF >55%
(n = 29, LVEF mean 61 ± 3%) were compared to the control
group (LVEF mean 65 ± 5%), aortic stiffness index was  signiﬁ-
cantly higher (6.11 ± 3.64 vs. 4.45 ±1.55; p = 0.03) and EAo velocity
was signiﬁcantly lower in the CAD group (7.34 ± 2.15 cm/s vs.
9.23 ± 2.38 cm/s; p = 0.01) whereas SAo velocities were similar
between the two groups (p = 0.34). In smokers (83 subjects),
aortic stiffness index (median 4.86, IQR 3.39 vs. median 3.51,
IQR 2.43; p = 0.01) distensibility (median 3.04 × 10−6 cm2/dyn,
IQR 2.11 × 10−6 cm2/dyn vs. median 4.19 × 10−6 cm2/dyn, IQR
3.11 × 10−6 cm2/dyn; p = 0.01), and elastic modulus (median
66.5 kPa, IQR 43.8 kPa vs. median 52.4 kPa, IQR 35.8 kPa; p = 0.03)
were signiﬁcantly different from nonsmokers (33 subjects). There
were no signiﬁcant differences in aortic TDI parameters including
SAo, EAo, and AAo in the smokers compared to the non-smokers
(p = 0.14, p = 0.75, p = 0.67, respectively).
There was a signiﬁcant correlation between EAo velocity and
aortic stiffness index (r = −0.28, p = 0.01), distensibility (r = 0.19,
p = 0.04), and elastic modulus (r = −0.24, p = 0.01). There was  no
correlation between SAo, AAo, and any of the aforementioned
parameters of AS. In addition, EAo velocities were correlated with
LVEF (r = −0.27, p = 0.01), LV mass index (r = −0.24, p = 0.01), Ea
(r = 0.32, p = 0.01), fasting glucose (r = −0.24, p = 0.01), and HDL
cholesterol levels (r = 0.31, p = 0.01). Systolic aortic velocity and AAo
were not correlated with any of these variables.
Univariate logistic regression analysis revealed higher glucose
level, lower HDL cholesterol level, higher aortic stiffness index,
higher elastic modulus, and lower Ea and EAo velocities as possi-
ble correlates of CAD in the study cohort (Table 3). As, EAo, aortic
stiffness index, aortic distensibility, and elastic modulus were inter-
correlated they were analyzed separately in a multivariate model
adjusted for glucose and HDL cholesterol levels and Ea veloci-
ties. In multivariate regression analysis, decreased levels of HDL
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Table 1
Demographic characteristics, clinical and biochemical parameters of the study population.
CAD (n = 50) Control (n = 70) p-Values
Age, mean ± SD 35.0 ± 3.6 34.1 ± 3.9 0.47
Male/female, n 41/9 58/12 0.90
BMI  (kg/m2) 27.6 ± 4.3 26.6 ± 4.2 0.21
Smoker (current), n (%) 39 (78) 48 (68.5) 0.26
Hypertension, n (%) 10 (20) 8 (11.4) 0.20
Diabetes mellitus, n (%) 3 (6) 1 (1.4) 0.17
Hyperlipidemia, n (%) 14 (28) 7 (10) 0.02
Family history of CAD, n (%) 19 (38) 20 (28.5) 0.27
Systolic BP (mmHg) 122.5 ± 15.8 122.2 ± 11.6 0.92
Diastolic BP (mmHg) 78.1 ± 11.4 77.3 ± 8.3 0.68
Pulse pressure (mmHg) 44.4 ± 9.1 44.9 ± 9.3 0.76
Heart rate (beats/min) 75.1 ± 6.9 75.6 ± 8.9 0.34
Diagnosis
STEMI, n (%) 37 (74) –
NSTEMI, n (%) 13 (26) –
Culprit vessel
LAD, n (%) 34 (68) –
RCA,  n (%) 8 (16) –
CX, n (%) 6 (12) –
Multivessel disease, n (%) 2 (4) –
Medical treatment
Beta blocker, n (%) 44 (88) 5 (7.1) 0.01
ACEI, n (%) 38 (76) 5 (7.1) 0.01
ARB,  n (%) 3 (6) 3 (4.2) 0.69
Statin, n (%) 45 (90) 3 (4.2) 0.01
Laboratory parameters
Hemoglobin (g/dL) 14.3 ± 1.8 14.6 ± 1.7 0.41
WBC  (×103/L) 8400 ± 2050 7450 ± 1790 0.02
Glucose (mg/dL) 96.5 ± 12.4 91.5 ± 8.6 0.01
Cholesterol (mg/dL) 183.6 ± 57.6 191.5 ± 38.8 0.49
Triglycerides (mg/dL) 174.2 ± 115.7 145.2 ± 74.2 0.22
HDL  (mg/dL) 37.5 ± 10.2 48.8 ± 10.4 <0.01
LDL  (mg/dL) 115.3 ± 49.5 122.7 ± 27.6 0.35
hs-CRP (mg/L) 0.78 ± 0.55 0.31 ± 0.40 0.01
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; BP, blood pressure; CAD, coronary artery disease; CX, circumﬂex
artery; HDL, high-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein; LAD, left anterior descending artery; LDL, low-density lipoprotein; NSTEMI, non-ST segment
elevation myocardial infarction; PCI, percutaneous coronary intervention; RCA, right coronary artery; SD, standard deviation; STEMI, ST segment elevation myocardial
infarction; WBC, white blood cell count.
Table 2
Conventional echocardiographic and aortic stiffness parameters of the study population.
CAD (n = 50) Control (n = 70) p-Value
LVDD (mm)  50.6 ± 4.6 47.7 ± 3.7 0.01
LVSD  (mm) 35.3 ± 5.7 30.1 ± 3.9 0.01
LVEF  (%) 55 ± 8 65 ± 5 0.01
LV  mass index (g/m2) 83.1 ± 17.7 71.1 ± 13.7 0.01
LA  volume index (cm3/m2) 18.7 ± 5.1 13.8 ± 3.6 0.01
Mitral inﬂow parameters
E  (cm/s) 79.7 ± 17.1 83.5 ± 15.2 0.24
A  (cm/s) 62.7 ± 12.8 59.7 ± 11.5 0.21
DT  (ms) 188.6 ± 31.4 186.1 ± 28.9 0.79
RT  (ms) 88.4 ± 14.1 83.9 ± 15.8 0.23
Sa (cm/s) 9.1 ± 2.1 9.9 ± 1.9 0.06
Ea (cm/s) 11.6 ± 3.5 14.7 ± 3.3 0.01
Aa (cm/s) 8.9 ± 2.1 8.8 ± 2.5 0.88
Aortic elasticity and TDI parameters
Systolic aortic diameter (mm)  30.9 ± 2.8 28.4 ± 3.1 0.01
Diastolic aortic diameter (mm)  28.1 ± 2.9 25.7 ± 2.9 0.01
Aortic SIa 5.40 (5.98) 4.14 (2.43) 0.03
Distensibility (×10−6 cm2/dyn)a 2.86 (2.51) 3.46 (2.38) 0.04
Elastic modulus (kPa)a 69.6 (56.9) 60.2 (36.4) 0.14
SAo (cm/s) 10.9 ± 2.4 10.6 ± 2.6 0.49
EAo (cm/s) 7.2 ± 1.8 9.2 ± 2.4 0.01
AAo (cm/s) 10.6 ± 3.3 10.1 ± 2.5 0.34
A, mitral inﬂow late diastolic velocity; Aa, annular late diastolic velocity; AAo, aortic wall late diastolic velocity; DT, left ventricular deceleration time; E, mitral inﬂow early
diastolic velocity; Ea, annular early diastolic velocity; EAo, aortic wall early diastolic velocity; EF, ejection fraction; IRT, isovolumic relaxation time; LA, left atrium; LV, left
ventricle; LVDD, left ventricular diastolic diameter; LVEF, left ventricular ejection fraction; LVSD, left ventricular systolic diameter; Sa, systolic myocardial velocity; SAo,  aortic
wall  systolic velocity; SI, stiffness index; TDI, tissue Doppler imaging.
a Data are expressed as median (interquartile range).
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Table  3
Univariate and multivariate logistic regression analysis of possible variables correlated with premature coronary artery disease.
Univariate analysis Multivariate analysis
OR (95% CI) p OR (95% CI) p
Age, 1-SD increase 1.08 (0.98–1.19) 0.12 –
Male gender 0.95 (0.36–2.44) 0.91 –
Systolic BP, 1-SD increase 1.01 (0.97–1.03) 0.82 –
BMI, 1-SD increase 1.06 (0.96–1.15) 0.19 –
Smoking 1.63 (0.71–3.75) 0.26 –
Glucose, 1-SD increase 1.07 (1.02–1.11) 0.01 1.03 (0.98–1.09) 0.38
Triglycerides, 1-SD increase 1.003 (0.99–1.007) 0.22 –
LDL,  1-SD increase 0.99 (0.98–1.00) 0.35 –
HDL, 1-SD decrease 1.13 (1.07–1.19) 0.01 1.08 (1.02–1.14) 0.01
Ea,1-SD decrease 1.32 (1.16–1.51) 0.01 1.17 (0.96–1.39) 0.07
Aortic stiffness parameters
EAo, 1-SD decrease 1.54 (1.26–1.89) 0.01 1.32 (1.03–1.69)a 0.03
Aortic SI, 1-SD increase 1.28 (1.09–1.50) 0.01 1.18 (0.97–1.44)a 0.09
Distensibility, 1-SD decrease 1.06 (0.89–1.24) 0.52 0.89 (0.71–1.13)a 0.35
Elastic modulus, 1-SD increase 1.01 (1.00–1.02) 0.02 1.006 (0.99–1.02)a 0.42
B  diasto
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dMI, body mass index; BP, blood pressure; CI conﬁdence interval; Ea, annular early
DL,  low-density lipoprotein; OR odds ratio; SD, standard deviation; SI stiffness ind
a These parameters were analyzed separately in multivariate model adjusted for
holesterol and EAo measurements remained as the variables inde-
endently correlated with premature CAD in the study group.
iscussion
Our study has two  main clinical implications. First, arterial
tiffness which is mainly driven by aging is abnormal in patients
ounger than 40 years old (mean age 35 years) with CAD. Sec-
nd, EAo of the ascending aortic wall measured by TDI is decreased
n patients with premature CAD and is correlated with previously
eﬁned AS parameters.
Hypertension, hyperlipidemia, diabetes mellitus, smoking,
nﬂammation, and positive family history for CAD are well deﬁned
ardiovascular risk factors and may  play a role in early develop-
ent of CAD. Whereas, these risk factors do not fully explain the
ncreased risk of cardiovascular disease in subjects with a family
istory of premature CAD. Mulders et al. showed that pulse-wave
elocity (PWV) is increased in individuals with a positive fam-
ly history for premature CAD [10]. The authors concluded that
WV  measurements may  be used in risk stratiﬁcation of individuals
ith a probable genetic predisposition to premature CAD. However,
tudies investigating the direct relationship between arterial stiff-
ning and anatomical measures of atherosclerosis (such as carotid
ntima media thickness) have reported contradictory results [4–8].
t is not well established whether AS is just a bystander or an active
layer that accelerates atherosclerotic changes.
Carotid-femoral PWV  is the best validated method for non-
nvasive quantiﬁcation of arterial stiffness [24]. Age and BP are
he major determinants of the PWV  measurements and respec-
ively, account for 23.5% and 13.8% of the amount of variability in
arotid femoral PWV  [25]. Echocardiography- and magnetic reso-
ance imaging-derived indices of AS have also been deﬁned and
ave shown good correlation with PWV  measurements [12,26,27].
ulse wave or strain TDI of the ascending aorta may  be used
o measure aortic wall velocities. These parameters have been
ound to be abnormal in patients with CAD, hypertension, diabetes
ellitus, LV diastolic dysfunction, and subclinical hypothyroidism
11,13,14,28–31]. Recently, Sen et al. reported that aortic propa-
ation velocities are lower in CAD patients compared to non-CAD
ubjects and are correlated with aortic stiffness parameters [32].
Vitarelli et al. showed that aortic stiffness index, SAo, EAo, and
ortic wall peak systolic radial strain were statistically lower in
ypertensive subjects when compared to the control group [11].
uh et al. found correlation of EAo, but not SAo, with aortic SI and
istensibility and showed that EAo is signiﬁcantly reduced in anlic velocity; EAo, aortic wall early diastolic velocity; HDL, high-density lipoprotein;
cose, and HDL cholesterol levels.
abnormal LV ﬁlling group in hypertensive subjects [28]. In another
study, aortic strain, aortic distensibility, and SAo and EAo velocities
of ascending aorta were signiﬁcantly lower in subjects with CAD
and diabetes mellitus [12]. The correlation of SAo, EAo, and AAo with
LVEF and stroke volume has not been well established. In our study,
even though LVEF was lower in the CAD group, in subgroup analysis,
we found that EAo velocities were lower in subjects with CAD and
preserved LV systolic function compared to the controls. Previously
the correlation of EF with SAo velocities has been shown [12]. This
correlation is logical as the stroke volume mainly causes expansion
of the aorta which is represented as the SAo velocity in aortic TDI
examination. In our study, SAo velocities were similar in the CAD
and control groups, which might indicate that the effect of reduced
EF was minimal in our comparisons.
In our study, we showed that in subjects with premature CAD,
aortic stiffness index was  higher and aortic distensibility was  lower
indicating arterial stiffening in this patient population. In addition,
a pulse-wave TDI parameter, early diastolic velocity, EAo was sig-
niﬁcantly lower in the CAD group. Signiﬁcant difference was  not
present regarding SAo and AAo. In multivariate logistic regression
analysis EAo velocity and HDL cholesterol levels were the indepen-
dent correlates of premature CAD. The frequency of hypertension
and diabetes mellitus, which may  cause arterial stiffening, were
low in the study population. Absence of confounding factors in the
study groups has resulted in better interpretation of the correla-
tion of AS with CAD. The frequency of smoking, which increases
AS, was high both in the CAD and control groups [33]. We  found
increased AS in smokers with M-mode-derived parameters of AS
but not with TDI-derived parameters. As the CAD group had with-
drawn smoking during the hospitalization period this might have
affected the ﬁndings and resulted in an insigniﬁcant difference of
aortic TDI parameters.
Our ﬁndings are conﬁrmatory to the results of Mulders et al. who
reported increased AS in patients with premature CAD and their
ﬁrst-degree relatives compared to the controls [10]. Nonetheless,
there are some differences to be mentioned: we used M-mode and
pulse-wave TDI derived indices of AS; our study group was com-
posed of younger individuals (35 years vs. 45 years) and the rate of
risk factors especially smoking was similar between the groups in
our study whereas it was higher in the CAD group of the previous
study. In addition, we  found abnormal AS parameters measured by
M-mode echocardiography in smokers compared to nonsmokers.
The clinical use of aortic stiffness parameters in CVD risk prediction
may  be age-related and have higher prognostic value in subjects
younger than 65 years [34].
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The possible mechanisms of early development of coronary
therosclerosis in subjects with increased AS have been proposed
s: (1) coexistence of diffuse atherosclerosis of aorta and coronary
rteries; (2) increase of pressure load on myocardium that causes
ncrease of oxygen demand; (3) decreased coronary perfusion gra-
ient due to decreased diastolic blood pressure; (4) accompanying
ndothelial dysfunction [35,36]. Chronic inﬂammation plays a role
n cardiovascular diseases such as CAD, aorta aneurysm, and aortic
issection. Thus, microvascular and macrovascular abnormalities
riggered by chronic inﬂammation may  be a common pathway in
rogress of CAD and arterial stiffening. In our study, patients with
remature CAD had higher high-sensitivity C-reactive protein lev-
ls and white blood cell counts. But, we could not differentiate the
ause of this difference whether it was secondary to myocardial
nfarction or secondary to the presence of chronic inﬂammation.
Even though, our ﬁndings show a correlation between M-mode
nd pulse-wave TDI parameters of ascending aorta with premature
evelopment of CAD, we may  not claim a causal role of AS in the
athogenesis of atherosclerosis and CAD.
imitations
There are some caveats in our study. Using a cross-sectional
esign, we can only observe an association between vascular
arameters and CAD, but cannot establish a causal relationship.
nd, our data may  not indicate the clinical use of aortic TDI param-
ters in clinical practice for risk stratiﬁcation purposes in patients
ithout CAD. Event though, inﬂammatory markers were higher in
he premature CAD group, the impact of inﬂammation in acceler-
ted atherosclerotic process needs further investigation especially
n subjects without established CAD. Decreased LV function may
ave an impact on aortic stiffness parameters. Whereas, a previous
rial has shown correlation of LVEF with SAo velocity (which was not
igniﬁcantly different between the two groups in our study) [12]. In
ddition, we repeated the analysis using ANCOVA model adjusted
or LVEF which conﬁrmed that EAo velocities were decreased in
atients with premature CAD. Nevertheless, the impact of stroke
olume changes on aortic TDI velocities needs further investiga-
ion. We  successfully measured aortic TDI parameters in all of the
tudy participants, however low image quality may  impair these
easurements. Although we have adjusted for all of the major
onfounders in the analysis, the presence of unknown confounders
annot be ignored.
onclusion
Increased AS has recently been recognized as a predictor of
ardiovascular events. Our ﬁndings verify this ﬁnding in a cohort
onsisting of subjects under 40 years old with CAD. Pulse-wave TDI
f the ascending aorta is a readily available method for estimat-
ng aortic elastic properties and EAo velocities are correlated with
reviously deﬁned parameters of AS.
Thus, EAo velocities may  indicate increased AS in patients with
remature CAD. The clinical use of this parameter needs further
nvestigation.
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